Corrigendum to “The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease”

Table 2

Liver enzymes, kidney function, lipids, and oxidative stress markers at baseline and 45 and 90 days.

Measure	Reference range	Time	RBAC	Placebo
ALP (U/L)	Male (40–129); Female (35–104)	Baseline	86 ± 37.6 (47, 172)	86.1 ± 31.8 (44, 141)
		45 days	81.2 ± 27.5 (45, 130)	91.8 ± 39.8 (43, 168)
		90 days	80 ± 25.4 (50, 140)	96.8 ± 38.1 (46, 159)
ALT (U/L)	Male (0–40); Female (0–35)	Baseline	39.4 ± 21.9 (12, 74)	57.8 ± 37 (13, 114)
		45 days	35.9 ± 22.9 (11, 83)	59 ± 42.7 (16, 140)
		90 days	38.6 ± 30.5 (13, 118)	55.4 ± 49 (13, 165)
AST (U/L)	Male (0–43); Female (0–32)	Baseline	28.8 ± 10.3 (17, 48)	42.6 ± 20.2 (14, 92)
		45 days	29.2 ± 13.4 (15, 56)	43.3 ± 22.1 (20, 83)
		90 days	30.4 ± 17.9 (17, 81)	44.4 ± 30.3 (19, 120)
AST/ALT ratio	Male (<1); Female (<1)	Baseline	0.86 ± 0.31 (0.58, 1.44)	0.9 ± 0.34 (0.48, 1.39)
		45 days	0.95 ± 0.33 (0.58, 1.54)	0.9 ± 0.36 (0.56, 1.65)
		90 days	0.92 ± 0.32 (0.57, 1.67)	1.02 ± 0.42 (0.52, 1.72)
γ-glutamyl transferase (IU/L)	0–51	Baseline	67.5 ± 80.6 (13, 304)	78.6 ± 87.7 (8, 300)
		45 days	51.4 ± 49.3 (15, 182)	83.1 ± 74.1 (14, 248)
		90 days	46.7 ± 38.1 (13, 126)	98.2 ± 94.6 (15, 291)
Albumin (g/dL)	3.5–5.2	Baseline	4.6 ± 0.3 (4.1, 4.9)	4.5 ± 0.4 (3.6, 4.9)
		45 days	4.5 ± 0.2 (4.3, 4.7)	4.5 ± 0.5 (3.3, 5.2)
		90 days	4.5 ± 0.3 (4, 4.9)	4.6 ± 0.5 (3.5, 5)
Non-HDL cholesterol (mg/dL)	<100 for healthy subjects; <80 for subjects with coronary artery disease	Baseline	142.5 ± 26.7 (81, 184)	146.7 ± 68.8 (36, 275)
		45 days	147.9 ± 33.6 (103, 214)	143.3 ± 65.7 (33, 247)
		90 days	142.8 ± 28.1 (96, 206)	144.6 ± 55.7 (37, 220)
4-Hydroxynonenal (μg/mL)	None	Baseline	121.1 ± 163.6 (6.2, 588.1)	144.5 ± 203 (5.7, 636.9)
		45 days	112.7 ± 150.8 (13.3, 534.7)	252.4 ± 367.4 (5.9, 1035.7)
		90 days	75.9 ± 50.8 (19.4, 157.7)	911.3 ± 2,258.3 (7.9, 6,485.6)

Values are mean ± standard deviation (minimum, maximum). ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; HDL, high-density lipoprotein. Percent change difference () from baseline to 90 days.